Side-by-side financials for ASMB and AZN. Every figure below comes from audited SEC filings and refreshed market data.
| Metric | ASMB | AZN |
|---|---|---|
| Market cap | - | $286.27 B |
| US-listed rank | - | #49 |
| Revenue (latest FY) | $72.30M | - |
| Net income (latest FY) | -$6.12M | - |
| Net margin | -8.5% | - |
| SEC filings | 873 | 1,004 |
Full pages: ASSEMBLY BIOSCIENCES, INC. and AstraZeneca PLC, or browse the full rankings.